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Abstract 
Objectives: To evaluate a weblog (blog)-based course introducing pharmacogenetics (PGt) and personalized medicine (PM) relative 
to freshmen pharmacy students’ knowledge base. Methods: Incoming freshmen pharmacy students were invited by email to enroll in 
a one semester-hour, elective, on-line blog-based course entitled “Personal Genome Evaluation”. The course was offered during the 
students’ first semester in college. A topic list related to PGt and PM was developed by a group of faculty with topics being presented 
via the blog once or twice weekly through week 14 of the 15 week semester. A pre-course and post-course survey was sent to the 
students to compare their knowledge base relative to general information, drug response related to PGt, and PM. Results: Fifty-one 
freshmen pharmacy students enrolled in the course and completed the pre-course survey and 49 of the 51 students completed the 
post-course survey. There was an increase in the students’ general, PGt and PM knowledge base as evidenced by a statistically 
significant higher number of correct responses for 17 of 21 questions on the post-course survey as compared to the pre-course 
survey. Notably, following the course, students had an increased knowledge base relative to “genetic privacy”, drug dosing based on 
metabolizer phenotype, and the breadth of PM, among other specific points. Conclusions: The study indicated that introducing PGt 
and PM via a blog format was feasible, increasing the students’ knowledge of these emerging areas. The blog format is easily 
transferable and can be adopted by colleges/schools to introduce PGt and PM. 
 
 
Introduction 
Healthcare providers, health professions students, and the lay 
public face a growing need for knowledge of genetics, 
pharmacogenetics (PGt) and personalized medicine (PM).1-4 
Genetics education, including PGt, of current and future 
healthcare professionals is lagging as compared to other 
components of PM.5 Thousands of individuals graduate from 
health professions programs annually and will enter their 
professions at a time when genetic, including PGt, 
information will likely be available for a larger population of 
patients. A benchmarking survey to represent the U.S. 
physician population regarding adoption of PGt testing was 
performed. With respect to PGt, only 29% of 10,303  
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physicians (M.D. and D.O.; specialists and general 
practitioners) had received any level of education regarding 
this type of testing.6 While 53% of 728 pharmacists had 
received any type of education in genetics, only 18% rated 
their current understanding of PGt as good, very good, or  
excellent.7 Similarly, only 13% of 206 nurses rated their 
knowledge of PGt testing above poor or fair.8 
 
A 2010 report indicated that 92% of colleges and schools of 
pharmacy included PGt in their curricula, an increase from 
78% as reported in 2005.9,10 However, the extent to which 
PGt was incorporated into curricula as required didactic hours 
varied greatly, with approximately 41% of colleges offering 10 
or fewer hours, 42% offering 11 to 30 hours, and 14% of 
schools offering 31 to 60 hours of instruction.9 Three percent 
of colleges did not report the number of didactic hours 
dedicated to PGt in their curricula.9 
 
The study described here measured freshmen pharmacy 
students’ knowledge of PGt and PM before and after an 
elective one-semester course (15 weeks) offered via a weblog 
(blog).  The specific aim of this study was to evaluate the 
impact of the blog course on the students’ knowledge base 
relative to PGt and PM. The course served to introduce the 
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topics of PGt and PM, allowing the students to build on this 
foundational information as they progressed through the 
pharmacy curriculum.   The pharmacy curriculum at Ohio 
Northern University (ONU) includes over 30 hours of 
instruction regarding PGt, PM, and related topics as has been 
previously described.11 However, the curriculum lacks an 
introductory component of basic PGt, and other fundamental 
aspects of PM as a foundation. The emerging field of PGt has 
resulted in the inclusion of “Pharmacogenomics/genetics” in 
Appendix B, “Additional Guidance on the Science Foundation 
for the Curriculum” of the Accreditation Council for 
Pharmaceutical Education (ACPE) standards effective 2011 
and more recently as “Required Elements of the Didactic 
Doctor of Pharmacy Curriculum” in the draft 2016 ACPE 
standards.12,13  Therefore, with a need to introduce PGt and 
PM education in our curriculum, we evaluated an innovative 
approach to presenting introductory material; Specifically, we 
utilized a weblog approach applying a faculty member’s 
direct-to-consumer (DTC) genetic testing results, including 
PGt test results, in the context of the broader topic of PM as a 
means to introduce these topics. 
 
The “Personal Genome Evaluation” Course Design 
Over the last seven years, the Raabe College of Pharmacy at 
ONU has worked to expand PGt education throughout the 
zero-six program. In an effort to develop an introductory 
course in PGt and PM, a study was undertaken to evaluate 
the use of a blog course to increase the knowledge base of 
freshmen students. The blog course content was designed by 
a group of faculty members encompassing various disciplines 
with interests related to PGt and PM (pharmacy, genetics, 
law, and ethics). The faculty developed “discussion points” 
which were based on information from various sources 
including the “Accreditation Standards and Guidelines - 
Professional Program In Pharmacy Leading to the Doctor of 
Pharmacy Degree”, effective February 14, 2011 from the 
ACPE, “The Case for Personalized Medicine”, 3rd Edition, 
from the Personalized Medicine Coalition, and general 
biology and genetics reference textbooks.5,12,14,15  The 
discussion points were grouped into categories, including 
general knowledge, disease risk, drug sensitivity, personalized 
medicine, ethics, and law, all of which addressed PGt and/or 
PM. A “master list” of the discussion points was developed 
for use during a 15 week semester elective course entitled 
“Personal Genome Evaluation”. This design was used to 
identify key aspects of PGt and PM with the intent to increase 
foundational knowledge by providing examples of the 
application of PGt and PM. As an example, during week four 
of the course, the topic was “Would you want to know?” and 
presented information related to Alzheimer’s disease, raising 
the issues of disease risk and ethics, related to PM.  
 
A faculty member served as the course coordinator and 
utilized six general knowledge, three disease risk, three drug 
sensitivity, four personalized medicine, and two ethics/legal 
discussion points as a basis for the course. The discussion 
points were presented through 14 weeks of the 15 week 
course via the blog found at www.pgxcheck.com (Table 1). 
Some of the discussion points presented during a given week 
were related to more than one category, e.g. disease 
risk/ethics (Week 4). A weblog template purchased through 
an online vendor (www.networksolutions.com; Web.comTM, 
Jacksonville, FL) was used to house the blog content. The 
course started on August 26, 2013, with the first blog entry 
on September 4, 2013 and the course ended December 20, 
2013. A faculty member utilized their own DTC testing results, 
provided by 23andMe, for the blog discussion. The faculty 
member information was used as it was related to an actual 
individual the students would recognize, making the 
information more “tangible” to the students. The faculty 
member agreed to use their own data and did not have to 
provide “third-party” data to the students. 
 
A description of the course was emailed to approximately 165 
incoming freshmen pharmacy students. The freshmen 
students were considered “P1” students in a “zero-six” 
program. The email described that the course was offered to 
the students to present and discuss data/ information from a 
DTC company for an individual, relative to “disease risk, drug 
response, and ethical, legal, and social issues”. The course 
was graded satisfactory/unsatisfactory and was available for 
academic credit as a one-hour semester course. 
 
The DTC company 23andMe was chosen because of the 
breadth of disease risk and drug response information 
provided and the lower cost of testing compared to other 
DTC companies. For the purposes of this course the disease 
risk and drug response information provided by 23andMe 
was utilized. Throughout the 15-week semester, on six 
occasions, results from the genetic testing of this individual 
were presented via the blog for discussion (Table 1). 
 
A computer-based pre-course survey to test the students’ 
knowledge base was developed using the above mentioned 
documents and was tested by ten freshmen students at the 
end of the previous spring semester. The test group students 
were not enrolled in the “Personal Genome Evaluation” 
course and had no formal coursework in PGt or PM. However, 
seven of the students noted they had “some exposure” to 
PGt and PM, while three students had never heard of the 
topic. The pre-course survey consisted of three demographic, 
four general knowledge (GK), ten personalized medicine (PM) 
questions, and seven drug response (DR) questions (see 
Tables 3 through 5). The test group responded to items 
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regarding the survey questions. All ten of the test group 
students found that the survey “was clear as to what each 
question was asking”, and confirmed that no single question 
“gave away” the answer to another question. Six of the 
students admitted “guessing” the answer to at least one 
question. The test group students took five to 18 minutes to 
complete the survey, with four students noting the survey 
“took too long”, while the remaining six students noted the 
time to complete the survey was “just right”. Having tested 
the survey, the pre-course survey was then distributed via 
email to the students enrolled in the Fall 2013 elective 
course. The intent of the surveys was to allow for summative 
assessment relative to the “instructional unit” that was the 
blog course. The pre-course survey served as the 
“benchmark” to which an identical post-course survey, minus 
the demographic questions, was compared. The pre- and 
post-course surveys were identical to that tested by the 10 
freshmen students the previous semester. Each survey was 
distributed to the students via an email utilizing the Qualtrics 
survey system (www.qualitrics.com; Qualtrics® LLC, Provo, 
UT). 
 
Students enrolled in “Personal Genome Evaluation” were 
required to read the blog entry and response posts during 
each week. The response posts were to be provided by 
students and faculty. The students were not required to post 
a reply, although they were encouraged to do so by 
prompting in the original once- or twice-weekly blog posts. 
The response posts were to be provided during the week 
following original post and at anytime thereafter until the end 
of the course. Faculty response posts were to be provided, 
when desired to respond to the student posts. Therefore, the 
discussion of any given topic would progress as desired by the 
students via their posts to the blog until the end of the 
course. The students were required to take short; three to 
five question “self-tests”, approximately every two weeks in 
an effort to keep them informed of blog entries, including the 
original posts and subsequent comments. The self-tests were 
not graded events, rather they asked questions directly from 
the original and response posting to the blog in order to help 
keep the students “up to speed” with the blog content. At the 
conclusion of the course, students were required to submit a 
one- to two-page paper describing three things they learned 
about “Personal Genome Evaluation” relative to PGt and PM. 
The topics of the “Three things I learned” paper were chosen 
from four categories, including disease risk, drug response, 
privacy, and other. Additionally, at the conclusion of the 
course, a course evaluation instrument was sent to all 
students enrolled in the course as part of Ohio Northern 
University (ONU) institutional research. This instrument 
consisted of standardized questions used across all courses at 
the University. The ONU Institutional Review Board exempted 
the study from review. 
 
Students received a “satisfactory” grade for the course if they 
completed all of the “self-tests” and turned in the “Three 
things I learned paper”. 
Survey results were evaluated using summary descriptive 
statistics. Overall correct responses from the pre-course and 
post-course surveys were compared using a two-sample T-
test assuming equal variance. Comparisons of individual pre-
course and post-course survey question responses were 
made using the Chi-Square test for the categorical data. For 
all statistical analyses, the level of significance was set a priori 
at a p-value of less than 0.05. Microsoft Excel 2007 (Microsoft 
Corp., Redmond, WA), and GraphPad Prism v5.04 (GraphPad 
Software Inc., La Jolla, CA) were utilized for statistical 
analyses. 
 
Results 
Demographics of Students 
Fifty-one freshmen students enrolled in the “Personal 
Genome Evaluation” elective course. Additionally, three 
upperclassmen enrolled in the course. Table 2 presents the 
demographic information for these groups. Twelve freshmen 
students (23.5% of the freshmen cohort) noted that they had 
“some exposure” to PGt or PM prior to this course. 
 
Pre- and Post-Survey 
All 51 freshmen students completed the pre-course survey, 
while 49 (96%) completed the post-course survey. 
Upperclassmen were excluded from the survey analysis. 
Tables 3, 4, and 5 present the pre- and post-course survey 
comparison of the number and percentage of correct 
responses for GK, PM, and drug response related to PGt, 
respectively. The correct answer for each question in Table 3, 
4, and 5, are presented in the Appendix. Overall, 17 of 21 
post-course survey questions had a statistically significantly 
higher number of correct responses as compared to the pre-
course survey. When taking the total number of students 
with correct responses pre- and post-course, there was a 
statistically significant increase in freshmen student 
knowledge base, following the course (20 + 13 vs. 37 + 10; p < 
0.001). For the cohort of freshmen students, there was a 
statistically significant increase in GK as noted in three of the 
four representative survey questions (Table 3). There was 
increase knowledge of PM in the freshmen student group as 
nine of ten questions showed a statistically significant 
increase in correct responses post-course as compared to 
pre-course (Table 4). With respect to the DR questions, a 
statistically significant higher number of correct answers 
were provided by the freshmen students post-course as 
compared to pre-course for five of seven questions (Table 5). 
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Blog Participation 
In total, there were 121 response postings to the blog 
covering the breadth of topics as described in Table 1. Most 
of the comments were related to disease risk (34.7%), 
personalized medicine and drug sensitivity (29.8%), and 
ethical/legal issues (23.1%), with the remainder of the 
responses being related to other topics. 
 
“Three Things I Learned” Paper 
The freshmen students were required to write a paper 
describing “three things I learned” from the “Personal 
Genome Evaluation” course. The papers included 41 
descriptions (26.5% of all descriptions) of what students 
learned about disease risk, 45 descriptions (29%) related to 
drug response, 44 descriptions (28.4%) related to privacy, and 
25 descriptions (16.1%) of what students learned about 
“other” topics, e.g., drug targets. It should be noted that 
some students included more than three descriptions. 
 
Course Evaluation 
Seventy percent of all students (n = 38) completed a course 
evaluation instrument offered by the Office of Institutional 
Research at ONU. As this course was intended to introduce 
the topics of PGt and PM, a question addressed to what 
extent the students felt that the course (“Personal Genome 
Evaluation”) “provided them with the skill set (here 
knowledge base) needed for further studies in the field.” Of 
these students, 84% (n = 32) of the evaluation instrument 
respondents agreed or strongly agreed with the statement, 
while 13% (n = 5) neither agreed nor disagreed with the 
statement and 3% (n = 1) disagreed with the statement. 
 
Discussion 
Graduates of health professions programs will likely 
encounter more patients that have had genetic testing 
performed with specific panels (e.g. CYP2C9, CYP2C19 and 
CYP2D6) or genome sequencing in part, or in whole as the 
cost of technology continues to decline.17 These healthcare 
professionals will need to understand the information 
provided and be able to interpret data and communicate the 
information to their patients. The “Personal Genome 
Evaluation” course was intended to introduce freshmen 
pharmacy students to PGt and PM. As compared to the pre-
course survey, the post-course survey reflected that the 
student’s knowledge of PGt and PM had increased after the 
blog discussion of data/information for an individual as 
provided by a DTC genetic testing company. 
 
There was a significant increase in general knowledge when 
considering three of four questions including what chemicals 
are considered DNA “building blocks”, the genetic influence 
on drug response being consistent over one’s lifetime, and 
the DNA similarity between individuals. There was no 
difference however; in pre- versus post-course knowledge 
relative to understanding that DNA is found in all nucleated 
cells in the body. With this specific topic, 88.2% of the 
students chose the correct answer on the pre-course survey 
and 96.1% of the students chose the correct answer on the 
post-course survey. The high percentage of correct responses 
on the pre-course survey likely reflects the influence of high-
school or other pre-college/college biology education. 
Additionally, the freshmen students were enrolled in a 
general biology course during the same semester, which 
introduced the concepts underlying the structure and 
function of cells including their organization, chemical 
foundations, metabolism, and the principles and mechanisms 
of heredity and gene expression. When discussing the 
questions included in the pre- and post-course survey with 
the coordinator of the general biology course, it was 
confirmed that the general knowledge question content for 
questions 1 and 2 (Table 3) were definitively discussed in the 
general biology course. There was likely some impact of the 
concurrent general biology course on the post-course survey 
results relative to GK. Regardless, the blog approach 
introduction of the general biology information was new 
material, reinforced by the biology course information, or 
reinforced the material presented in the biology course. 
 
Personalized medicine in the context of inclusion of genetic 
test results is relatively new and with no freshmen student 
having had formal education on the subject, it was expected 
that “Personal Genome Evaluation” would be of benefit 
relative to the freshmen students’ knowledge base. Here, 
students increased their knowledge relative to genetic 
privacy and legal protections being introduced to the Genetic 
Information Nondiscrimination Act of 2008 (Table 4; 
questions 1 and 8). The students were introduced to health 
information technology and became familiar with the Health 
Information Technology for Economic and Clinical Health 
(HITECH) Act (Table 4, question 4). Disease risk stimulated 
much conversation on the blog with the posts relative to this 
topic receiving the most student responses (42; 34.7% of all 
response postings). Importantly, the post-course survey 
showed that 85.7% of students correctly identified disease 
risk as being relative as compared to 14.3% of the students 
pre-course. All questions related to disease risk (Table 4; 
questions 5, 6, and 7) showed a statistically significant 
increase with respect to correct answers being chosen post-
course as compared to pre-course. More students 
understood “participatory medicine”, where molecular 
genetic information is combined with the patient’s 
environment, lifestyle, diet, and family history, as well as the 
patient’s observation of their own symptoms post-course as 
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compared to pre-course (Table 4, question 9; p < 0.0001). A 
statistically significant higher percentage of students 
recognized the breadth of personalized medicine post-course 
as compared to pre-course (83.7% vs 41.2%), understanding 
that many sectors must be integrated to reach full 
implementation of PM (Table 4; question 10). 
Students were introduced to “drug targets” with 91.8% being 
able to identify the targets post-course as compared to 23.5% 
pre-course (p < 0.0001; Table 5, question 1). While 
pharmacodynamics was discussed, students did not improve 
their knowledge base relating gene-drug receptor variation as 
a pharmacodynamic interaction (Table 5, question 2), with 
11.8% and 22.4% of students identifying the correct answer 
on the pre-course and post-course surveys, respectively. 
Students grasped the idea of metabolic phenotypes having 
increased their knowledge base when asked to identify a 
phenotype or determine how a phenotype would be related 
to dose (Table 5; questions 3, 4, and 7). While 63% of the 
students post-course versus 55% pre-course identified that 
extensive metabolizers would require a higher dose than an 
intermediate metabolizer to achieve the same drug exposure, 
the difference did not reach statistical significance (Table 5; 
question 5). 
 
Of interest, the majority of topics discussed in the “Three 
Things I Learned” papers were related to “disease risk”. The 
papers included ethical, legal, and social issues as well as the 
Food and Drug Administration’s actions toward 23andMe 
relative to reporting disease risk and drug response 
information. Importantly, as was noted in the post-course 
survey, students discussed the understanding that disease 
risk data was relative and not absolute. Similarly, students 
expressed some caution when using the drug response data, 
noting other influences of how a drug may affect an 
individual.  
 
An important aspect of the blog format was the 
“conversation” that occurred as students posted responses to 
the topics. This approach encouraged student to “voice” their 
opinion and ask questions. Responses by the three 
upperclassmen likely added to the education of the other 
students as the upperclassmen comments were a result of 
having had formal courses which included PGt and PM 
information. While one faculty member served as the course 
coordinator and posted the blog topics, other faculty added 
their comments to the discussion. Again, this served as an 
important process for providing the students with more 
information to assimilate, further increasing their knowledge 
base. The weblog format of the course allowed for broad 
discussion, with discussion points being a permanent part of 
the weblog, such that students could return to the discussion 
as many times as desired. Unlike the classroom setting where 
a discussion occurs and then ends, with details often being 
lost, the documentation of the discussion via the weblog 
provides a “retrievable dialogue” that students can refer to 
and contemplate. While not specifically recorded, it is likely 
the students visited the discussions more than just once as 
comments were added to each discussion throughout the 15 
week semester. Additionally, the weblog format may have 
allowed for broader representation of opinions as students 
are more likely to participate in an online discussion as 
opposed to offering an opinion in the “live” classroom 
setting. Importantly, this format also allows for responses to 
instructor and participant posts in a broader context of 
differing viewpoints.18 
 
The purchase of a blog template was important as it 
minimized the time for set-up and maintenance of the blog 
course. There was no programming experience required and 
template functions allowed for addition of tables and images 
to enhance explanation of information. The instructor simply 
entered the blog topic and initial post in the fields provided in 
the template and respondents posted in the “comment” field. 
The cost of the blog template, including the domain name 
(www.pgxcheck.com) was approximately $7 per month and in 
total the annual cost with additional features, such as 
advanced technical support was approximately $250. The 
cost of online resources through Network Solutions was 
comparable to other vendors. The choice of this vendor had 
to do with the apparent online support made available. The 
associated cost of the technology was deemed to be justified 
and was supported by College funds. These considerations, 
i.e., the blog template, relatively low cost and available 
support, by the noted vendor and others, make the weblog 
course approach readily adoptable by other colleges/schools. 
Additionally, the pharmacogenetic testing results, as part of 
broader genetic testing via a DTC company were obtained at 
a cost of $207. The saliva sample for genetic testing was 
provided to the company eight weeks in advance of the 
offering to allow for test results to be returned in time for the 
course offering. The total cost to present the “Personal 
Genome Evaluation” course was just over $450.  
 
Faculty time commitment per week included approximately 
20 to 40 minutes to write and post the blog topic and up to 
10 minutes to read reply comments. The development and 
posting the “self-tests”, based on the blog posts required 30 
minutes of faculty time every other week. The largest time 
commitment was related to reading the “Three things I 
learned” papers at the end of the semester. The papers were 
submitted electronically to the instructor during week 14 of 
the semester. This allowed for reading time during week 
fifteen, prior to course grade submission. The time to read all 
54 papers was approximately seven hours. 
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Conclusions 
As the need for PGt education increases, colleges/schools of 
pharmacy will be looking to include introductory material in 
their curricula. As described, the weblog-based course, 
“Personal Genome Evaluation” provided freshmen students 
with an introduction to PGt and PM which increased their 
knowledge base and prepared them for further study of the 
subjects. The blog format, via available, affordable online 
technology, when combined with pharmacogenetic testing 
results can be easily transferable and can be adopted by 
colleges to introduce PGt and PM. 
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Case Study EDUCATION 
 
Table 1. The website (www.pgxcheck.com) blog topics relative to the “Personal Genome Evaluation”  
course from faculty derived points of discussion and direct-to-consumer testing data. 
 
Week Topic Category Specific Discussion Points 
1 www.pgxcheck.com - Blog site for the course 
- Confirmation of blog URL. 
2 Looking at a Personal Genome. Why? General Described the rationale for getting tested. 
2 
Personal Genome...The Process and Initial 
Thoughts 
General Described the process of sample collection and the 
procedure for sending the sample and obtaining the 
results. 
2 Introductory Information and Disease Risk: Prostate Cancer! 
Disease Risk 
(PMa) 
Background information on DNA and single nucleotide 
polymorphisms (SNPs) and risk of prostate cancer. 
3 A quick look at DNA, Amino Acids, and Proteins 
General (GKb) Background information on DNA, Amino Acids, and 
Proteins. 
3 Disease Risk - Coronary Heart Disease (CHD) 
Disease Risk 
(PM) 
Background information on DNA and SNPs and risk of 
coronary heart disease. Via drugsandgenes.com.16 
4 Would you want to know? Disease Risk/ Ethics (PM) 
Background information and SNPs and risk of Alzheimer’s 
Disease. 
5 
Genetic Discrimination - An example and 
the law 
Ethics/Law (PM) Examination of the Burlington Northern & Santa Fe 
Railway company case and introduction to the Genetic 
Information Nondiscrimination Act (GINA). 
5 Expanding GINA Ethics/Law (PM) A look at what some states are doing beyond the federal 
GINA. 
6 Let's Talk Personalized Medicine, 
Pharmacogenetics, and 
Pharmacogenomics! 
General (PM) Definitions of and an introduction to personalized 
medicine, pharmacogenetics, and pharmacogenomics. 
6 A preliminary look at drug response: 
Caffeine 
Drug Sensitivity 
(DRc) 
An example of relating genetics to drug response. 
7 Chest Pain, Coronary Artery Blockage and 
My Antiplatelet Therapy! 
Drug Sensitivity 
(DR) 
A second example of relating genetics to drug response. 
8 Metabolizer Phenotypes General (DR) Defining phenotype and relating genotype to phenotype. 
9 If I had atrial fibrillation and needed warfarin... 
Drug Sensitivity 
(DR) 
An example where two genetic variations can influence 
drug response. 
10 What is a drug-gene interaction? General (DR) Defining a drug-gene interaction with examples. 
11 The Breadth of Personalized Medicine - 
Personal Genome Evaluation 
Personalized 
Medicine (PM) 
Examination of the components of personalized 
medicine. 
12 Education and Personalized Medicine - A 
challenge to you! 
Personalized 
Medicine (PM) 
Identifying the need for education in personalized 
medicine and citing informational sources. 
13 23andMe Personalized 
Medicine (PM) 
A discussion about recent events related to the Food and 
Drug Administration’s letter to the direct-to-consumer 
DNA testing company 23andMe. 
14 
The Personalized Medicine Pie and 
related items 
Personalized 
Medicine (PM) 
Revisiting, with more specificity, the components of 
personalized medicine. Here introducing the document 
“The Case for Personalized Medicine”.5 
aPersonalized Medicine; bGeneral Knowledge; cDrug Response 
 
  
http://z.umn.edu/INNOVATIONS                   2014, Vol. 5, No. 2, Article 151                             INNOVATIONS in pharmacy   7 
 
Case Study EDUCATION 
 
Table 2. Demographics of pharmacy student population that enrolled in the  
“Personal Genome Evaluation” course, based on the pre-course survey. 
 
Age Range: na (%) 
17 through 19 years 
20 through 25 years 
52 (96.3) 
2 (3.7) 
Academic Year:  
Freshmen 
Junior 
51 (94.4) 
3 (5.6) 
Gender:  
Male 
Female 
10 (18.5) 
44 (81.5) 
Primary Language:  
English 54 (100) 
Prior Use of DTC Genetic Testing:  
No 54 (100) 
Previous PGt or PM Education:  
Formal course work 0 (0) 
Some exposure 15 (27.8) 
Never heard of topics 39 (72.2) 
Member of sPMC Chapterb  
Yes 1 (1.9) 
No 53 (98.1) 
an = 54. bsPMC refers to the student chapter of the Personalized Medicine Coalition. 
 
 
 
 
Table 3. General knowledge questions; Pre- and post-course 
 correct responses (number; percentage), and p value.a, b 
 
Question 
Pre-course 
Number 
Correct 
(%) 
Post-course 
Number 
Correct 
(%) 
p Value 
1. True or False. All nucleated cells in the body contain DNA. 45 (88) 47 (96) 0.1569 
2. The four chemicals that are the "building blocks" of DNA include 
which of the following? 39 (76) 48 (98) 0.0014 
3. True or False. Genetic influence of drug response changes over a 
person’s lifetime. 11 (22) 29 (59) <0.0001 
4. Based on DNA only, humans are ________ % alike. 16 (31) 48 (100) <0.0001 
astatistical significance set a priori at a p value < 0.05. bsee Appendix for correct answers 
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Case Study EDUCATION 
 
Table 4. Personalized medicine questions; Pre- and post-course  
correct responses (number; percentage), and p value.a, b 
 
Question 
Pre-course 
Number 
Correct 
(%) 
Post-course 
Number 
Correct 
(%) 
p Value 
1. The U.S, federal legislation enacted to protect individuals from 
discrimination relative to personal genetic information is known as: 5 (10) 47 (96) <0.0001 
2. Personalized medicine can improve patient care by: 43 (86) 45 (94) 0.2054 
3. Personalized medicine and pharmacogenomics have been 
brought closer to clinical use mainly because: 11 (22) 32 (63) <0.0001 
4. Electronic health records and other information technologies 
must be implemented for use in healthcare. Which legislation states 
that hospitals and physicians face penalties if they do not use these 
technologies in a "meaningful way" after 2015? 
16 (31) 32 (65) p<0.0001 
5. A person sends their saliva to a direct-to-consumer genetic 
testing company. The results show that the individual has a single 
nucleotide polymorphism (SNP) which is related to increased risk of 
coronary heart disease. This risk is considered: 
16 (31) 42 (86) <0.0001 
6. True or False. In cancer patients, the genetics of some tumors can 
be used to identify drugs that can target the cancer cells. 35 (69) 45 (92) 0.0037 
7. True or False. The genetics of all tumor cells associated with 
cancer have been determined. 40 (78) 47 (96) <0.0001 
8. The legislation passed to prohibit discrimination based on a 
person's genetics is aimed at which two groups? 16 (31) 46 (94) <0.0001 
9. Participatory medicine includes which of the following along with 
molecular genetic information? 7 (14) 24 (50) <0.0001 
10. Which of the following must "converge" in order for 
personalized medicine to be fully implemented? (check all that 
apply) 
21 (41) 41 (84) <0.0001 
astatistical significance set a priori at a p value < 0.05. bsee Appendix for correct answers 
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Case Study EDUCATION 
 
Table 5. Drug response questions; Pre- and post-course  
correct responses (number; percentage), and p value.a. b 
 
Question 
Pre-course 
Number 
Correct 
(%) 
Post-course 
Number 
Correct 
(%) 
p Value 
1. Drug targets that are under genetic control include which of the 
following? 12 (24) 45 (92) <0.0001 
2. An individual has the genetic constitution that results in 
decreased formation of a specific drug receptor.  This causes the 
individual to be more "sensitive" to the effects of drugs that target 
this receptor.  This interaction between a drug and a receptor is 
called: 
6 (12) 11 (22) 0.1551 
3. A person sends their saliva to a direct-to-consumer genetic 
testing company.  The testing results show that this individual has a 
single nucleotide polymorphism (SNP) which is related to decreased 
activity of a metabolizing enzyme.  Specifically, the individual has 
the genetic constitution showing that one parent passed along a 
deficient gene, while the other parent passed along the "normal 
function" gene.  This individual is typically classified as a/an: 
16 (31) 30 (61) 0.0028 
4. Given a prodrug, a patient with a heterozygotic polymorphism 
reducing the metabolism of the drug would require a/an: 9 (18) 28 (57) <0.0001 
5. As compared to an intermediate metabolizer, an individual who is 
an extensive metabolizer would need a _________ dose to achieve 
a similar drug exposure. 
23 (45) 31 (63) 0.0684 
6. A drug is being studied in a large clinical trial.  The results indicate 
that only a small percentage of the patients in the study benefit 
from the drug.  Which of the following statements describes a 
rational "next step" in the development of the drug? 
33 (65) 41 (84) 0.0306 
7. Which individual would likely have two "common" copies (one 
from each parent) of the genes coding for a metabolizing enzyme? 14 (27) 32 (65) <0.0001 
astatistical significance set a priori at a p value < 0.05. bsee Appendix for correct answers   
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Case Study EDUCATION 
 
Appendix: Answers to pre- and post-course survey questions (see Tables 3, 4, and 5). 
 
General knowledge questions 
Q1. True 
Q2. Adenine, Cytosine, Guanine, and Thymine 
Q3. False 
Q4. 99.9% 
 
Personalized medicine questions 
Q1. Genetic Information Non-discrimination Act; GINA 
Q2. Identifying correct drug, avoiding adverse effects, increase medication adherence 
Q3. Technology making DNA testing more affordable 
Q4. Health Information Technology for Economic and Clinical Health; HITECH 
Q5. Relative 
Q6. True 
Q7. False 
Q8. Employers and health insurers 
Q9. The patient’s observations and the patient’s lifestyle, environment, diet and family history 
Q10. Technology/ tools, Regulation, Insurance coverage/ reimbursement, Genetic privacy/legal protections, Medical 
education, Healthcare information technology 
 
Drug response questions 
Q1. Receptors, Transporters, Drug Metabolizing Enzymes 
Q2. Pharmacogenetic – pharmacodynamic interaction 
Q3. Intermediate metabolizer 
Q4. Increased dose 
Q5. Higher 
Q6. Study the drug in the small group to identify if there is a genetic similarity among the patients 
Q7. E 
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